4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-040625
Chief Financial Officer bought 5,000 shares at $1.41 ($7,050)
From the SEC's structured data for this filing
Trades in this filing
Gerber Brianna · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-01 | Purchase : show line 1 in the form | +5,000 | $1.41 | $7,050 | 27,436 | D |
| Open-market purchases · 5,000 sh · avg $1.41 · $7,050 | ||||||
Loading xslF345X05/wk-form4_1701724341.xml…